{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:12:06Z","timestamp":1791331926376,"version":"4.3.1"},"reference-count":36,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.3892\/ijo.2013.2236","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T12:46:00Z","timestamp":1388407560000},"page":"865-873","source":"Crossref","is-referenced-by-count":19,"title":["Enhancement of differentiation induction and upregulation of CCAAT\/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid"],"prefix":"10.3892","volume":"44","author":[{"given":"NORIYOSHI","family":"IRIYAMA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BO","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUTA","family":"YOSHINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIHIRO","family":"HATTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIRA","family":"HORIKOSHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIN","family":"AIZAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAMI","family":"TAKEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIN","family":"TAKEUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NORIO","family":"TAKAGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROO","family":"TOYODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"key20180107182221_b1-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/35901","article-title":"Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia","volume":"391","author":"Grignani","year":"1998","journal-title":"Nature"},{"key":"key20180107182221_b2-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/35895","article-title":"Role of the histone deacetylase complex in acute promyelocytic leukaemia","volume":"391","author":"Lin","year":"1998","journal-title":"Nature"},{"key":"key20180107182221_b3-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/cbt.308","article-title":"Treatment of acute promyelocytic leukemia with ATRA and As2O3: a model of molecular target-based cancer therapy","volume":"1","author":"Fang","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"key20180107182221_b4-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"key20180107182221_b5-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02703936","article-title":"Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells","volume":"25","author":"Zhang","year":"2000","journal-title":"J Biosci"},{"key":"key20180107182221_b6-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","article-title":"Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia","volume":"93","author":"Melnick","year":"1999","journal-title":"Blood"},{"key":"key20180107182221_b7-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/asheducation-2008.1.391","article-title":"Curative strategies in acute promyelocytic leukemia","volume":"1","author":"Tallman","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20180107182221_b8-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.bbmt.2009.07.010","article-title":"Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen","volume":"15","author":"Thirugnanam","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20180107182221_b9-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180107182221_b10-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","article-title":"Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia","volume":"25","author":"Quint\u00e1s-Cardama","year":"2011","journal-title":"Leukemia"},{"key":"key20180107182221_b11-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107182221_b12-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.leukres.2007.03.012","article-title":"Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia","volume":"31","author":"Cheng","year":"2007","journal-title":"Leuk Res"},{"key":"key20180107182221_b13-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107182221_b14-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cncr.21552","article-title":"The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia","volume":"106","author":"Kuendgen","year":"2006","journal-title":"Cancer"},{"key":"key20180107182221_b15-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","article-title":"Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"key":"key20180107182221_b16-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1093\/emboj\/cdg556","article-title":"C\/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells","volume":"22","author":"Duprez","year":"2003","journal-title":"EMBO J"},{"key":"key20180107182221_b17-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1182\/blood-2008-10-182071","article-title":"Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia","volume":"114","author":"Guibal","year":"2009","journal-title":"Blood"},{"key":"key20180107182221_b18-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2005-07-3068","article-title":"ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression","volume":"107","author":"Mueller","year":"2006","journal-title":"Blood"},{"key":"key20180107182221_b19-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI2887","article-title":"CCAAT\/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment","volume":"103","author":"Park","year":"1999","journal-title":"J Clin Invest"},{"key":"key20180107182221_b20-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.exphem.2004.08.015","article-title":"Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, myeloid differentiation, and leukemogenesis","volume":"33","author":"Rosmarin","year":"2005","journal-title":"Exp Hematol"},{"key":"key20180107182221_b21-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12185-010-0686-6","article-title":"C\/EBPbeta and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitro","volume":"92","author":"Zhang","year":"2010","journal-title":"Int J Hematol"},{"key":"key20180107182221_b22-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of differentiation in human cancer: AML shows the way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107182221_b23-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.taap.2011.09.006","article-title":"Contribution of aquaporin 9 and multidrug resistance-associated protein 2 to differential sensitivity to arsenite between primary cultured chorion and amnion cells prepared from human fetal membranes","volume":"257","author":"Yoshino","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20180107182221_b24-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3892\/or.2012.2006","article-title":"Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A","volume":"28","author":"Iriyama","year":"2012","journal-title":"Oncol Rep"},{"key":"key20180107182221_b25-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.biocel.2008.09.031","article-title":"Direct contribution of inducible nitric oxide synthase expression to apoptosis induction in primary smooth chorion trophoblast cells of human fetal membrane tissues","volume":"41","author":"Yuan","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107182221_b26-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.leu.2401508","article-title":"Histone deacetylase inhibitors are the potent inducer\/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy","volume":"13","author":"Kosugi","year":"1999","journal-title":"Leukemia"},{"key":"key20180107182221_b27-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood.V90.7.2591","article-title":"A novel, myeloid transcription factor, C\/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation","volume":"90","author":"Morosetti","year":"1997","journal-title":"Blood"},{"key":"key20180107182221_b28-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02983213","article-title":"Granulocyte colony-stimulating factor-induced terminal maturation of human myeloid cells is specifically associated with up-regulation of receptor-mediated function and CD10 expression","volume":"77","author":"Inazawa","year":"2003","journal-title":"Int J Hematol"},{"key":"key20180107182221_b29-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.leu.2403226","article-title":"Rapid induction of cAMP\/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation","volume":"18","author":"Zhao","year":"2004","journal-title":"Leukemia"},{"key":"key20180107182221_b30-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1349-7006.2008.00728.x","article-title":"Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression","volume":"99","author":"Zhang","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107182221_b31-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0145-2126(01)00151-5","article-title":"Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways","volume":"26","author":"Kawagoe","year":"2002","journal-title":"Leuk Res"},{"key":"key20180107182221_b32-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/leu.2012.39","article-title":"Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL","volume":"26","author":"Leiva","year":"2012","journal-title":"Leukemia"},{"key":"key20180107182221_b33-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.leukres.2006.01.009","article-title":"Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells","volume":"30","author":"Deubzer","year":"2006","journal-title":"Leuk Res"},{"key":"key20180107182221_b34-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2011.12.041","article-title":"Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically","volume":"319","author":"Zapotocky","year":"2012","journal-title":"Cancer Lett"},{"key":"key20180107182221_b35-ijo-44-03-0865","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"key20180107182221_b36-ijo-44-03-0865","first-page":"263","article-title":"Application of arsenic trioxide therapy for patients with leukemia","volume-title":"Biological Chemistry of Arsenic, Antimony and Bismuth","author":"Yuan","year":"2011"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2013.2236\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T04:18:51Z","timestamp":1597292331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2013.2236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,30]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,12,30]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.3892\/ijo.2013.2236"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2013.2236","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,30]]}}}